UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 21, 2009

 

Retractable Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Texas

 

000-30885

 

75-2599762

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

 

 

 

511 Lobo Lane, Little Elm, Texas

 

75068-0009

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code  (972) 294-1010

 

None

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01               Other Events.

 

Retractable Technologies, Inc. (the “Company”) announces that it has been awarded a contract by the Department of Health and Human Services to supply a portion of the safety engineered syringes to be used in the United States’ efforts to vaccinate the US population against the H1N1 virus (swine flu).  The impact to the Company depends upon the timing and quantities of H1N1 vaccine available for US use.  The program is expected to run through March 2010.  The impact on the Company is uncertain, however, the Company anticipates that the related unit sales increase could be material.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

DATE:  August 31, 2009

 

 RETRACTABLE TECHNOLOGIES, INC.

 

 

(Registrant)

 

 

 

 

 

 

 

BY:

 s/ Thomas J. Shaw

 

 

 THOMAS J. SHAW

 

 

 PRESIDENT AND CHIEF EXECUTIVE OFFICER

 

2